Successfully operate one of the most lethal cancers by first burning the tumor with a needle



[ad_1]

Doctors at the Vall d? Hebron Hospital in Barcelona, ​​Spain, successfully operated three patients with advanced pancreatic cancer, the one with the worst prognosis and hitherto inoperable, using a pioneering technique that burns tumor cells.

It's about the radiofrequency, which was applied to neutralize locally advanced adenocarcinoma of the pancreas. This type of advanced cancer is considered the worst prognosis among pancreatic tumors, with a average survival of 11 months.

O adenocarcinomas of the pancreas locally advanced are not operable with traditional techniques due to the involvement of major arteries and veins and are not effective treatments such as chemotherapy or immunotherapy.

But intraoperative radiofrequency, applied as part of an international study led by Dutch specialists, allows the introduction of a needle directly into the tumor. destroying tumor cells through the heat. The three patients operated on with this new technique did not present any type of complication.

"The needle breaks the shield [tras el que se esconde el tumor] and allows us to apply temperatures up to 80ºC directly in the tumor area. These temperatures are so high they literally burn the tumor causing cell death. This process also facilitates the exposure of tumor components to the cells of the immune system attacking them, "explained Dr. Elizabeth Pando of Vall dHebron Hospital.

To prevent high temperatures from causing damage to the organs, arteries, and other vital areas that are close to the adenocarcinomas of the pancreas, the needle also has a cooling system, which allows the introduction of cooling fluids that reach areas such as the duodenum to prevent overheating.

The results of the study will be known in the year 2021. "If it is confirmed that this therapy is effective for locally advanced adenocarcinoma of the pancreas, we will finally have a technique that allows improve the prognosis of this tumor so malignant, "added Dr. Ramón Charco, head of the Hepatobiliary Surgery and Transplantation Service at the Spanish hospital.

[ad_2]

Source link